Nav: Home

British Journal of Cancer press notice

July 31, 2018

Please download the papers below or contact the BJC press office for the full paper or with any other questions on 0203 469 8300, out of hours, 07050 264 059 or bjcpress@cancer.org.uk. Scientists can be directly contacted regarding media interviews using the contact details provided.

Please reference the British Journal of Cancer in any media activity.

Paper: Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer
Corresponding author: Naomi Boekel
Telephone: +31205126292
E-mail: n.boekel@nki.nl

Author summary: Both radiotherapy and anthracycline-based chemotherapy are commonly used and highly effective breast cancer treatments. Unfortunately, they have also been associated with increased cardiovascular disease (CVD) risks. We studied the separate and combined effects of various treatments and established cardiovascular risk factors on the long-term risks of different CVDs in 14,645 breast cancer patients.

During 1970-2009, especially irradiation of the lymph nodes behind the sternum (IMC-irradiation) exposed the heart to high heart doses. This type of radiation is associated with ~2-fold increased rates of different CVDs compared to women receiving the lowest cardiac doses. In patients with an established cardiovascular risk factor, 20-year cumulative incidence of ischemic heart disease is 11% in patients with IMC-irradiation versus 6% in those without. Anthracyclines are associated with a four-fold increased heart failure rate, and combined with IMC-irradiation, a substantial, nine-fold increased rate was observed.

Current radiation techniques expose the heart to lower doses, and radiation-associated CVD risks are hence expected to be lower in patients treated today.

Post embargo link: https://www.nature.com/articles/s41416-018-0159-x

DOI: s41416-018-0159-x

Paper: The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer
Corresponding author: Jakob Søgaard Juul, MD, PhD
Telephone: 0045 61777404
E-mail: jsjuul.feap@outlook.dk

Author summary: The vast majority of individuals with colorectal cancer (CRC) are diagnosed via the general practitioner (GP). One of the major challenges is that about half of these patients present with vague and non-specific symptoms that do not raise suspicion of CRC. This makes it difficult for the GP to discover the cancer early. The present study is the first to investigate the use of a safe, low-cost faecal immunochemical test (FIT) in patients presenting with non-alarm symptoms of CRC in general practice. The results suggest that the FIT may be used in this patient population to detect CRC and other serious bowel diseases in primary care and that the stage distribution of detected CRC by this method may be favourable. The findings are of importance in a realistic diagnostic work-up of patients with non-alarm symptoms of CRC and it reveals a possible diagnostic supplement in general practice.

Post embargo link: https://www.nature.com/articles/s41416-018-0178-7

DOI: s41416-018-0178-7

Paper: Detection of Circulating Tumor Cell Clusters in Human Glioblastoma
Corresponding author: Prof Nicola Aceto
Telephone: +41-61-207-0773
E-mail: nicola.aceto@unibas.ch

Author summary: Human glioblastoma (GBM) is a highly aggressive malignant brain cancer. Circulating tumor cells (CTCs) are cancer cells that detach from a solid tumor lesion and enter the bloodstream, in the form of single CTCs or multicellular clusters (CTC clusters). Individual CTCs are sporadically found in GBM patients, yet, it has been unclear whether CTC clusters are generated in this disease and whether they can bypass the physical hurdle of the blood-brain barrier.

When analyzing the blood of 13 GBM patients, we observed CTC clusters at multiple sampling time-points in a patient with pleomorphism and extensive necrosis. DNA sequencing of these GBM CTC clusters highlighted alterations in 58 cancer-associated genes, many of which were also mutated in cells within the primary GBM tumor, but non-mutated in healthy cells from the same patient.

Thus, our findings represent the first evidence of the presence of CTC clusters in GBM, suggesting that clustered cancer cells are able to bypass the blood-brain barrier.

Post embargo link: https://www.nature.com/articles/s41416-018-0186-7

DOI: s41416-018-0186-7
-end-
The British Journal of Cancer is editorially independent of Cancer Research UK. The BJC is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention, diagnosis and treatment. The BJC is owned by Cancer Research UK and published by Springer Nature.

Cancer Research UK

Related Breast Cancer Articles:

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.
More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.
Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.
Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.
Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.
Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.
Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.
Does MRI plus mammography improve detection of new breast cancer after breast conservation therapy?
A new article published by JAMA Oncology compares outcomes for combined mammography and MRI or ultrasonography screenings for new breast cancers in women who have previously undergone breast conservation surgery and radiotherapy for breast cancer initially diagnosed at 50 or younger.
Blood test offers improved breast cancer detection tool to reduce use of breast biopsy
A Clinical Breast Cancer study demonstrates Videssa Breast can inform better next steps after abnormal mammogram results and potentially reduce biopsies up to 67 percent.
More Breast Cancer News and Breast Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.